SUO 2019: Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in High Grade Nonmuscle Invasive Bladder Cancer

SUO 2019 treatment for BCG unresponsive superficial high-grade NMIBC, radical cystectomy, combination of BCG and pembrolizumab, gene expression, pembrolizumab treatment, non-muscle invasive bladder cancer.

Read the full article here

Related Articles